Aris Kekedjian | executive |
John Gillard | executive |
James Sidoti | analyst |
Good day, and welcome to Trinity Biotech announces Second Quarter Financial Results. [Operator Instructions]. Please note that this event is being recorded. I'd like to turn the call over to Mr. Joe Diaz, Lytham Partners. Please go ahead.